NuvOx Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	0.27	0.13	1.66
Cash & Cash Equivalents	0.27	0.13	1.66
Cash Growth	-	-92.15%	-
Receivables	0.03	0.03	0.09
Other Current Assets	0.67	0.62	0.28
Total Current Assets	0.96	0.78	2.03
Property, Plant & Equipment	-	0.04	0.07
Goodwill and Intangibles	-	0.72	0.81
Total Long-Term Assets	-	0.76	0.88
Total Assets	-	1.54	2.91
Accounts Payable	-	3.57	1.27
Current Debt	-	0.09	0.12
Other Current Liabilities	5.49	0.45	0.14
Total Current Liabilities	5.49	4.1	1.53
Long-Term Debt	-	22.67	10.49
Other Long-Term Liabilities	-	0.31	0.13
Total Long-Term Liabilities	-	22.98	10.62
Total Liabilities	-	27.08	12.15
Total Debt	27.88	22.76	10.61
Debt Growth	-	114.39%	-
Retained Earnings	-	-36.27	-19.68
Shareholders' Equity	-32.16	-25.54	-9.24
Net Cash (Debt)	-27.61	-22.63	-8.96
Working Capital	-4.53	-3.32	0.5